Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Renal Artery Obstruction | 19 | 2015 | 38 | 2.610 |
Why?
|
Vascular Surgical Procedures | 12 | 2019 | 91 | 2.320 |
Why?
|
Lower Extremity | 7 | 2019 | 97 | 1.980 |
Why?
|
Ischemia | 8 | 2014 | 94 | 1.630 |
Why?
|
Blood Vessel Prosthesis Implantation | 6 | 2014 | 70 | 1.420 |
Why?
|
Stents | 9 | 2016 | 171 | 1.340 |
Why?
|
Hypertension, Renovascular | 8 | 2009 | 15 | 1.170 |
Why?
|
Renal Artery | 14 | 2015 | 43 | 1.150 |
Why?
|
Aortic Aneurysm, Abdominal | 6 | 2014 | 47 | 1.130 |
Why?
|
Postoperative Complications | 12 | 2020 | 674 | 1.010 |
Why?
|
Atherosclerosis | 8 | 2015 | 728 | 1.010 |
Why?
|
Angioplasty, Balloon | 6 | 2016 | 33 | 0.940 |
Why?
|
Kidney | 11 | 2009 | 488 | 0.940 |
Why?
|
Vascular Diseases | 4 | 2020 | 62 | 0.920 |
Why?
|
Aged | 50 | 2020 | 9572 | 0.910 |
Why?
|
Angioplasty | 5 | 2014 | 32 | 0.880 |
Why?
|
Treatment Outcome | 27 | 2019 | 3123 | 0.880 |
Why?
|
Anesthesia, General | 2 | 2012 | 29 | 0.820 |
Why?
|
Anesthesia, Conduction | 2 | 2012 | 29 | 0.810 |
Why?
|
Amputation | 3 | 2018 | 37 | 0.800 |
Why?
|
Male | 61 | 2020 | 17969 | 0.780 |
Why?
|
Quality Indicators, Health Care | 2 | 2019 | 55 | 0.780 |
Why?
|
Venous Thrombosis | 4 | 2012 | 49 | 0.760 |
Why?
|
Female | 57 | 2020 | 18341 | 0.740 |
Why?
|
Time Factors | 22 | 2019 | 2013 | 0.690 |
Why?
|
Humans | 65 | 2020 | 29449 | 0.680 |
Why?
|
Middle Aged | 36 | 2019 | 10920 | 0.660 |
Why?
|
Aged, 80 and over | 22 | 2017 | 3758 | 0.640 |
Why?
|
Ultrasonography, Doppler, Duplex | 13 | 2016 | 45 | 0.620 |
Why?
|
Aortic Aneurysm | 3 | 2011 | 12 | 0.570 |
Why?
|
Risk Assessment | 13 | 2014 | 1327 | 0.560 |
Why?
|
Risk Factors | 25 | 2020 | 3596 | 0.560 |
Why?
|
Mesenteric Vascular Occlusion | 4 | 2016 | 12 | 0.500 |
Why?
|
Retrospective Studies | 24 | 2020 | 3135 | 0.490 |
Why?
|
Embolectomy | 1 | 2014 | 3 | 0.490 |
Why?
|
Hypertension, Renal | 1 | 2014 | 29 | 0.480 |
Why?
|
Vena Cava Filters | 3 | 2010 | 14 | 0.480 |
Why?
|
Follow-Up Studies | 14 | 2020 | 2121 | 0.480 |
Why?
|
Thromboembolism | 1 | 2014 | 30 | 0.480 |
Why?
|
Aortography | 1 | 2014 | 16 | 0.480 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 40 | 0.470 |
Why?
|
Kidney Diseases | 6 | 2011 | 239 | 0.470 |
Why?
|
Blood Vessel Prosthesis | 1 | 2014 | 79 | 0.450 |
Why?
|
Tomography, X-Ray Computed | 5 | 2017 | 872 | 0.450 |
Why?
|
Software | 1 | 2014 | 110 | 0.450 |
Why?
|
Attitude of Health Personnel | 2 | 2015 | 163 | 0.450 |
Why?
|
Multivariate Analysis | 9 | 2017 | 638 | 0.450 |
Why?
|
Registries | 9 | 2017 | 280 | 0.450 |
Why?
|
Clinical Competence | 1 | 2015 | 310 | 0.430 |
Why?
|
Length of Stay | 6 | 2014 | 295 | 0.420 |
Why?
|
Prospective Studies | 14 | 2020 | 2041 | 0.420 |
Why?
|
Comorbidity | 8 | 2017 | 548 | 0.410 |
Why?
|
Logistic Models | 7 | 2017 | 729 | 0.410 |
Why?
|
Anesthesia, Local | 1 | 2011 | 16 | 0.400 |
Why?
|
Career Choice | 2 | 2015 | 40 | 0.400 |
Why?
|
Retinal Vessels | 2 | 2015 | 18 | 0.390 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 39 | 0.390 |
Why?
|
Arterial Occlusive Diseases | 4 | 2017 | 30 | 0.390 |
Why?
|
Patient Selection | 5 | 2014 | 257 | 0.390 |
Why?
|
Vena Cava, Inferior | 2 | 2010 | 31 | 0.380 |
Why?
|
Severity of Illness Index | 10 | 2014 | 864 | 0.370 |
Why?
|
Embolism, Cholesterol | 2 | 2007 | 6 | 0.370 |
Why?
|
Cardiovascular Diseases | 6 | 2015 | 1055 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 1389 | 0.360 |
Why?
|
Cardiovascular Agents | 1 | 2009 | 18 | 0.350 |
Why?
|
Education, Medical, Undergraduate | 1 | 2010 | 86 | 0.350 |
Why?
|
Societies, Medical | 3 | 2019 | 150 | 0.350 |
Why?
|
North Carolina | 10 | 2017 | 1428 | 0.340 |
Why?
|
Vascular Patency | 7 | 2017 | 68 | 0.340 |
Why?
|
Linear Models | 5 | 2017 | 427 | 0.330 |
Why?
|
Hand Strength | 2 | 2020 | 90 | 0.330 |
Why?
|
Students, Medical | 1 | 2010 | 121 | 0.330 |
Why?
|
Device Removal | 2 | 2010 | 31 | 0.310 |
Why?
|
Arteriosclerosis | 4 | 2005 | 116 | 0.310 |
Why?
|
Predictive Value of Tests | 10 | 2017 | 796 | 0.310 |
Why?
|
Creatinine | 9 | 2009 | 175 | 0.310 |
Why?
|
Reoperation | 4 | 2014 | 204 | 0.310 |
Why?
|
Prosthesis Implantation | 1 | 2007 | 35 | 0.300 |
Why?
|
Glomerular Filtration Rate | 9 | 2008 | 289 | 0.300 |
Why?
|
Saphenous Vein | 2 | 2017 | 20 | 0.290 |
Why?
|
Popliteal Vein | 1 | 2006 | 3 | 0.290 |
Why?
|
Femoral Vein | 1 | 2006 | 10 | 0.290 |
Why?
|
Iliac Vein | 1 | 2006 | 8 | 0.290 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2006 | 7 | 0.290 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 293 | 0.290 |
Why?
|
Prosthesis Design | 5 | 2014 | 87 | 0.280 |
Why?
|
Patient Discharge | 2 | 2020 | 170 | 0.280 |
Why?
|
Balloon Occlusion | 1 | 2006 | 29 | 0.280 |
Why?
|
Thrombectomy | 1 | 2006 | 58 | 0.280 |
Why?
|
Odds Ratio | 5 | 2017 | 448 | 0.270 |
Why?
|
Capillaries | 1 | 2005 | 23 | 0.270 |
Why?
|
Anticoagulants | 1 | 2006 | 122 | 0.260 |
Why?
|
Retinal Diseases | 1 | 2005 | 18 | 0.260 |
Why?
|
Patient Care Team | 2 | 2019 | 124 | 0.260 |
Why?
|
Cohort Studies | 11 | 2012 | 1701 | 0.250 |
Why?
|
Hospital Mortality | 3 | 2014 | 190 | 0.250 |
Why?
|
Blood Pressure | 10 | 2011 | 812 | 0.250 |
Why?
|
Aneurysm | 3 | 2014 | 21 | 0.240 |
Why?
|
Adult | 16 | 2017 | 8511 | 0.240 |
Why?
|
Thrombolytic Therapy | 2 | 2014 | 59 | 0.230 |
Why?
|
Coronary Disease | 1 | 2005 | 202 | 0.230 |
Why?
|
Embolism | 1 | 2003 | 6 | 0.220 |
Why?
|
Carotid Stenosis | 2 | 2013 | 56 | 0.220 |
Why?
|
Renal Circulation | 3 | 2014 | 13 | 0.220 |
Why?
|
Renal Dialysis | 4 | 2011 | 265 | 0.220 |
Why?
|
Incidence | 8 | 2015 | 1126 | 0.220 |
Why?
|
Equipment Failure Analysis | 1 | 2002 | 42 | 0.220 |
Why?
|
Thrombosis | 1 | 2003 | 60 | 0.210 |
Why?
|
Aortic Valve | 1 | 2002 | 48 | 0.210 |
Why?
|
Corneal Transplantation | 1 | 2002 | 13 | 0.210 |
Why?
|
Mitral Valve | 1 | 2002 | 28 | 0.210 |
Why?
|
Corneal Diseases | 1 | 2002 | 10 | 0.210 |
Why?
|
Heart Valve Prosthesis | 1 | 2002 | 53 | 0.210 |
Why?
|
Disease Progression | 6 | 2014 | 574 | 0.200 |
Why?
|
Databases as Topic | 2 | 2011 | 24 | 0.200 |
Why?
|
North America | 2 | 2011 | 33 | 0.200 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2014 | 469 | 0.180 |
Why?
|
After-Hours Care | 1 | 2019 | 6 | 0.180 |
Why?
|
Mesenteric Artery, Superior | 3 | 2016 | 8 | 0.170 |
Why?
|
Benchmarking | 1 | 2019 | 25 | 0.170 |
Why?
|
Survival Rate | 7 | 2020 | 796 | 0.170 |
Why?
|
Hospital Costs | 1 | 2019 | 36 | 0.170 |
Why?
|
Operating Rooms | 1 | 2019 | 32 | 0.170 |
Why?
|
Ventricular Function, Left | 2 | 2011 | 198 | 0.170 |
Why?
|
Population Surveillance | 2 | 2012 | 119 | 0.170 |
Why?
|
Muscle, Smooth, Vascular | 2 | 2013 | 71 | 0.170 |
Why?
|
United States | 8 | 2020 | 3685 | 0.160 |
Why?
|
Celiac Artery | 2 | 2016 | 6 | 0.160 |
Why?
|
Recurrence | 4 | 2016 | 235 | 0.160 |
Why?
|
Pulmonary Embolism | 2 | 2010 | 46 | 0.160 |
Why?
|
Longitudinal Studies | 5 | 2014 | 725 | 0.160 |
Why?
|
Prevalence | 6 | 2017 | 910 | 0.150 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 137 | 0.150 |
Why?
|
Psoas Muscles | 1 | 2017 | 19 | 0.150 |
Why?
|
Sex Distribution | 4 | 2009 | 188 | 0.150 |
Why?
|
Marital Status | 1 | 2017 | 20 | 0.150 |
Why?
|
Vertebral Artery | 1 | 2017 | 8 | 0.150 |
Why?
|
Cause of Death | 4 | 2020 | 222 | 0.150 |
Why?
|
Prognosis | 5 | 2020 | 1369 | 0.150 |
Why?
|
Sarcopenia | 1 | 2017 | 53 | 0.150 |
Why?
|
Heart Diseases | 1 | 2017 | 99 | 0.140 |
Why?
|
Disease-Free Survival | 2 | 2014 | 282 | 0.140 |
Why?
|
Mesenteric Arteries | 3 | 2006 | 18 | 0.140 |
Why?
|
Wounds, Gunshot | 1 | 2017 | 34 | 0.140 |
Why?
|
Blood Glucose | 1 | 2018 | 469 | 0.140 |
Why?
|
Specialties, Surgical | 1 | 2015 | 24 | 0.130 |
Why?
|
Age Distribution | 3 | 2009 | 199 | 0.130 |
Why?
|
Fibromuscular Dysplasia | 1 | 2015 | 2 | 0.130 |
Why?
|
Health Status Disparities | 1 | 2016 | 115 | 0.130 |
Why?
|
Hypertension | 4 | 2014 | 916 | 0.130 |
Why?
|
Microvessels | 1 | 2015 | 23 | 0.130 |
Why?
|
Fellowships and Scholarships | 1 | 2015 | 50 | 0.130 |
Why?
|
Graft Occlusion, Vascular | 2 | 2017 | 22 | 0.120 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 116 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2015 | 53 | 0.120 |
Why?
|
Reproducibility of Results | 2 | 2014 | 727 | 0.120 |
Why?
|
Limb Salvage | 1 | 2014 | 25 | 0.120 |
Why?
|
Furosemide | 1 | 2014 | 6 | 0.120 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2014 | 10 | 0.120 |
Why?
|
Fingers | 1 | 2014 | 57 | 0.120 |
Why?
|
Observer Variation | 1 | 2014 | 96 | 0.120 |
Why?
|
Endarterectomy, Carotid | 1 | 2013 | 29 | 0.120 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 88 | 0.110 |
Why?
|
Surgery, Computer-Assisted | 1 | 2014 | 56 | 0.110 |
Why?
|
Diastole | 2 | 2011 | 91 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 1 | 2013 | 41 | 0.110 |
Why?
|
Hyaluronic Acid | 1 | 2013 | 46 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 130 | 0.110 |
Why?
|
Oxygen | 1 | 2014 | 139 | 0.110 |
Why?
|
Academic Medical Centers | 1 | 2014 | 150 | 0.110 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2013 | 74 | 0.110 |
Why?
|
Internship and Residency | 1 | 2015 | 283 | 0.100 |
Why?
|
Critical Illness | 1 | 2012 | 88 | 0.100 |
Why?
|
Kidney Function Tests | 3 | 2009 | 102 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 1221 | 0.100 |
Why?
|
Ultrasonography | 4 | 2009 | 348 | 0.100 |
Why?
|
Lung Diseases | 1 | 2011 | 45 | 0.100 |
Why?
|
Evidence-Based Medicine | 2 | 2010 | 208 | 0.100 |
Why?
|
Venous Thromboembolism | 1 | 2011 | 25 | 0.100 |
Why?
|
Duodenum | 1 | 2010 | 5 | 0.100 |
Why?
|
Respiration, Artificial | 1 | 2011 | 96 | 0.100 |
Why?
|
Surgical Wound Infection | 1 | 2011 | 74 | 0.090 |
Why?
|
Aneurysm, False | 1 | 2010 | 13 | 0.090 |
Why?
|
Comprehension | 1 | 2010 | 19 | 0.090 |
Why?
|
Cognition Disorders | 1 | 2013 | 391 | 0.090 |
Why?
|
Program Development | 1 | 2010 | 85 | 0.090 |
Why?
|
Databases, Factual | 1 | 2011 | 333 | 0.090 |
Why?
|
Sepsis | 1 | 2011 | 149 | 0.090 |
Why?
|
Program Evaluation | 1 | 2010 | 176 | 0.090 |
Why?
|
Radiography | 4 | 2015 | 355 | 0.090 |
Why?
|
Cognition | 1 | 2013 | 528 | 0.090 |
Why?
|
Antihypertensive Agents | 3 | 2009 | 344 | 0.090 |
Why?
|
Geriatric Assessment | 2 | 2017 | 363 | 0.090 |
Why?
|
Morbidity | 3 | 2007 | 92 | 0.090 |
Why?
|
Probability | 2 | 2009 | 150 | 0.080 |
Why?
|
Proportional Hazards Models | 4 | 2017 | 711 | 0.080 |
Why?
|
Vascular Resistance | 1 | 2008 | 28 | 0.080 |
Why?
|
Renal Insufficiency | 2 | 2008 | 53 | 0.080 |
Why?
|
Curriculum | 1 | 2010 | 198 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2009 | 137 | 0.080 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2009 | 110 | 0.080 |
Why?
|
Aorta, Abdominal | 1 | 2008 | 26 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2010 | 861 | 0.080 |
Why?
|
Filtration | 1 | 2007 | 2 | 0.080 |
Why?
|
Hypothermia, Induced | 1 | 2007 | 16 | 0.080 |
Why?
|
Particle Size | 1 | 2007 | 43 | 0.080 |
Why?
|
Perfusion | 1 | 2007 | 64 | 0.080 |
Why?
|
Phlebography | 1 | 2007 | 26 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 328 | 0.070 |
Why?
|
Medical Records | 1 | 2007 | 68 | 0.070 |
Why?
|
Equipment Design | 1 | 2007 | 167 | 0.070 |
Why?
|
Injections, Intravenous | 1 | 2006 | 73 | 0.070 |
Why?
|
Ethnic Groups | 2 | 2015 | 440 | 0.070 |
Why?
|
Adolescent | 3 | 2004 | 3278 | 0.070 |
Why?
|
Age Factors | 4 | 2020 | 1120 | 0.070 |
Why?
|
Child | 2 | 2002 | 2228 | 0.070 |
Why?
|
Proteinuria | 1 | 2005 | 57 | 0.070 |
Why?
|
Photography | 1 | 2005 | 33 | 0.060 |
Why?
|
Heart Function Tests | 1 | 2005 | 4 | 0.060 |
Why?
|
Ultrasonography, Doppler | 1 | 2005 | 18 | 0.060 |
Why?
|
Retina | 1 | 2005 | 50 | 0.060 |
Why?
|
Sex Factors | 3 | 2016 | 633 | 0.060 |
Why?
|
Viscera | 1 | 2004 | 17 | 0.060 |
Why?
|
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2004 | 2 | 0.060 |
Why?
|
European Continental Ancestry Group | 2 | 2005 | 1132 | 0.060 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2004 | 44 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2005 | 455 | 0.060 |
Why?
|
Peritonitis | 1 | 2003 | 10 | 0.060 |
Why?
|
New Zealand | 1 | 2002 | 8 | 0.050 |
Why?
|
Aging | 2 | 2005 | 888 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2005 | 376 | 0.050 |
Why?
|
African Americans | 2 | 2005 | 1375 | 0.050 |
Why?
|
Chronic Disease | 2 | 2016 | 371 | 0.050 |
Why?
|
Infant, Newborn | 1 | 2002 | 604 | 0.040 |
Why?
|
Models, Economic | 1 | 2019 | 18 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2010 | 141 | 0.040 |
Why?
|
Hyperplasia | 2 | 2013 | 38 | 0.040 |
Why?
|
Specialization | 1 | 2019 | 30 | 0.040 |
Why?
|
Cost Savings | 1 | 2019 | 32 | 0.040 |
Why?
|
Carotid Arteries | 2 | 2013 | 97 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 161 | 0.040 |
Why?
|
Infant | 1 | 2002 | 975 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 1380 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2019 | 121 | 0.040 |
Why?
|
Child, Preschool | 1 | 2002 | 1171 | 0.040 |
Why?
|
Angiography | 2 | 2009 | 75 | 0.040 |
Why?
|
Muscle Strength Dynamometer | 1 | 2017 | 11 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 2017 | 29 | 0.040 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 59 | 0.040 |
Why?
|
Frail Elderly | 1 | 2017 | 66 | 0.040 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2017 | 7 | 0.040 |
Why?
|
Cells, Cultured | 2 | 2013 | 802 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 713 | 0.040 |
Why?
|
Retreatment | 1 | 2016 | 40 | 0.040 |
Why?
|
Nephrectomy | 2 | 2010 | 114 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2016 | 44 | 0.040 |
Why?
|
Community Health Services | 1 | 2015 | 54 | 0.030 |
Why?
|
Health Status | 1 | 2017 | 371 | 0.030 |
Why?
|
Perception | 1 | 2015 | 92 | 0.030 |
Why?
|
Risk | 1 | 2015 | 292 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2013 | 53 | 0.030 |
Why?
|
Administration, Oral | 1 | 2014 | 172 | 0.030 |
Why?
|
Cell Shape | 1 | 2013 | 26 | 0.030 |
Why?
|
Collagen Type I | 1 | 2013 | 39 | 0.030 |
Why?
|
Acute Disease | 1 | 2014 | 239 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 247 | 0.030 |
Why?
|
Mice | 2 | 2013 | 2383 | 0.030 |
Why?
|
Cerebrovascular Circulation | 1 | 2013 | 95 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2013 | 103 | 0.030 |
Why?
|
Decision Support Techniques | 1 | 2014 | 104 | 0.030 |
Why?
|
Hemodynamics | 1 | 2013 | 148 | 0.030 |
Why?
|
Cell Movement | 1 | 2013 | 161 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 380 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 823 | 0.030 |
Why?
|
Survival Analysis | 2 | 2004 | 440 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2013 | 425 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 525 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 748 | 0.020 |
Why?
|
Electrocardiography | 1 | 2015 | 568 | 0.020 |
Why?
|
Mass Screening | 1 | 2012 | 226 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 40 | 0.020 |
Why?
|
Craniocerebral Trauma | 1 | 2010 | 56 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 669 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2010 | 55 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2013 | 983 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 2009 | 55 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2010 | 178 | 0.020 |
Why?
|
Rats | 1 | 2013 | 1607 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2009 | 108 | 0.020 |
Why?
|
Intermittent Claudication | 1 | 2008 | 10 | 0.020 |
Why?
|
Animals | 2 | 2013 | 7328 | 0.020 |
Why?
|
Hospitalization | 1 | 2010 | 422 | 0.020 |
Why?
|
Stroke Volume | 1 | 2009 | 282 | 0.020 |
Why?
|
Endarterectomy | 1 | 2005 | 7 | 0.020 |
Why?
|
Sampling Studies | 1 | 2005 | 40 | 0.020 |
Why?
|
Nephrosclerosis | 1 | 1995 | 4 | 0.020 |
Why?
|
Systole | 1 | 2005 | 88 | 0.020 |
Why?
|
Mesenteric Artery, Inferior | 1 | 2004 | 2 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2004 | 7 | 0.010 |
Why?
|
Gels | 1 | 2004 | 33 | 0.010 |
Why?
|
Tunica Intima | 1 | 2004 | 59 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 72 | 0.010 |
Why?
|
Brachial Artery | 1 | 2004 | 66 | 0.010 |
Why?
|
Aorta | 1 | 2004 | 103 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 162 | 0.010 |
Why?
|
Collagen | 1 | 2004 | 218 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 641 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2002 | 49 | 0.010 |
Why?
|
Random Allocation | 1 | 2002 | 213 | 0.010 |
Why?
|
Weight Loss | 1 | 2004 | 415 | 0.010 |
Why?
|